HETTA ATKINS: Open Payments
NPI 1881945830 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 18 payments from 15 companies in 2025. Trend: 2023 $925 · 2024 $4,684 · 2025 $582
Food & beverage: $497Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $128 |
| SOBI, INC | 2 | $117 |
| Boston Scientific Corporation | 1 | $55 |
| BeiGene USA, Inc. | 1 | $48 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Genentech USA, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $23 |
| Incyte Corporation | 1 | $22 |
| Abbott Laboratories | 1 | $19 |
Products named: RYBREVANT, LUX-Dx Insertable Cardiac Monitor, BRUKINSA, KEYTRUDA, Vonjo, FRUZAQLA, Polivy, VENCLEXTA.
Industry payments across TX — which companies pay providers there.
